# OnCo record paper-barroso-sousa-tmb-pten-ici-mtnbc-ccr-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-barroso-sousa-tmb-pten-ici-mtnbc-ccr-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-barroso-sousa-tmb-pten-ici-mtnbc-ccr-2020" ;
  schema:name "Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer"@en ;
  schema:description "In 62 women with metastatic triple-negative cancer treated with immunotherapy, high mutation burden (18%) went with a year of progression-free time versus under four months, while PTEN loss (29%) went with almost no responses."@en ;
  schema:url <https://onco.cc/key-papers/paper-barroso-sousa-tmb-pten-ici-mtnbc-ccr-2020/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-19-3507>, <https://pubmed.ncbi.nlm.nih.gov/32019858/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-19-3507> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Barroso-Sousa R, Keenan TE, Pernas S, et al." ;
  onco:related <https://onco.cc/biomarkers/tmb-high/>, <https://onco.cc/biomarkers/pten-alteration/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-metastatic/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pten/>, <https://onco.cc/targets/pdl1/>, <https://onco.cc/targets/pd1/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/> ;
  onco:terms <https://onco.cc/terms/tmb/> ;
  onco:people <https://onco.cc/people/sara-tolaney/>, <https://onco.cc/people/nancy-lin/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .